Add like
Add dislike
Add to saved papers

Synthesis and Evaluation of Troponoids as a New Class of Antibiotics.

ACS Omega 2018 November 31
Novel antibiotics are urgently needed. The troponoids [tropones, tropolones, and α-hydroxytropolones (α-HT)] can have anti-bacterial activity. We synthesized or purchased 92 troponoids and evaluated their antibacterial activities against Staphylococcus aureus , Escherichia coli , Acinetobacter baumannii, and Pseudomonas aeruginosa . Preliminary hits were assessed for minimum inhibitory concentrations (MIC80 ) and cytotoxicity (CC50 ) against human hepatoma cells. Sixteen troponoids inhibited S. aureus / E. coli / A. baumannii growth by ≥80% growth at <30 μM with CC50 values >50 μM. Two selected tropolones ( 63 and 285 ) inhibited 18 methicillin-resistant S. aureus (MRSA) strains with similar MIC80 values as against a reference strain. Two selected thiotropolones ( 284 and 363 ) inhibited multidrug-resistant (MDR) E. coli with MIC80 ≤30 μM. One α-HT ( 261 ) inhibited MDR- A. baumannii with MIC80 ≤30 μM. This study opens new avenues for development of novel troponoid antibiotics to address the critical need to combat MDR bacterial infections.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app